The Japanese Journal of Pharmacology · 1992 · 18 citations · 13 references
MedicinePharmacologyBiochemical PharmacologyInflammationPharmacodynamicsAnti-inflammatory PharmacologyInflammatory ProcessesJoint DiseaseRheumatoid ArthritisSynovial InflammationArachidonic Acid MetabolitesArachidonic Acid SignalingHyaluronan BiologySynovial Fibroblasts
The effects of hyaluronan (HA) on the release of arachidonic acid (AA) from phospholipids induced by bradykinin in synovial fibroblasts of osteoarthritic patients were examined. HA inhibited [14C]AA release from prelabeled synovial cells stimulated with and without bradykinin 1 hr after incubation with HA and thereafter. The inhibitory effects of HA on [14C]AA release were dependent on the concentration and molecular weight of HA. However, inhibition of [14C]AA release by HA was not merely due to the viscosity of HA. The [14C]AA release induced by calcium-ionophore A23187 was also inhibited by HA with a high molecular weight. In addition, HA did not affect [14C]AA uptake by the cells. Our results suggest that HA with a high molecular weight elicits anti-inflammatory effects, at least in part, by inhibiting AA release in inflamed joints.
13
Lauritz Bredrup Dahl, I. M. Dahl, Anna Engström‐Laurent et al. · Annals of the Rheumatic Diseases · 1985 · 547 citations
Ronald M. Burch, J Axelrod · Proceedings of the National Academy of Sciences · 1987 · 375 citations · Full text